All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

502

Reset

502 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • QD202Phase 21 trial

    Shanghai QuietD Biotechnology Co., Ltd. · Acute Ischemic Stroke

  • QHRD106MiddlePhase 21 trial

    Changzhou Qianhong Bio-pharma Co., Ltd. · Acute Ischemic Stroke

  • RDX-002Phase 21 trial

    Response Pharmaceuticals · Triglycerides, Weight Gain Trajectory, Cholesterol, Elevated

  • RedasemtideRedasemtide trifluoroacetate, S-005151Phase 21 trial

    Shionogi · Acute Ischemic Stroke

  • REGN13335Phase 21 trial

    Regeneron · Pulmonary Arterial Hypertension (PAH)

  • REGN22530Phase 21 trial

    Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)

  • REGN5381Phase 21 trial

    Regeneron · Heart Failure

  • RGT001-075Phase 21 trial

    Regor Pharmaceuticals Inc. · Obesity or Overweight

  • RMC-035Phase 21 trial

    Guard Therapeutics AB · Kidney Injury Following Open-Chest Cardiac Surgery

  • RN0361Phase 21 trial

    Ikaria Bioscience Pty Ltd · Hypertriglyceridemia, Familial Chylomicronemia Syndrome

  • RN3161Phase 21 trial

    Ikaria Bioscience Pty Ltd · Obesity &Amp; Overweight

  • RO7446603Phase 21 trial

    Roche (Genentech) · Diabetic Macular Edema

  • ROC-101Phase 21 trial

    AllRock Bio, Inc. · Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease

  • RTN-001SLx-2101Phase 21 trial

    Retension Pharmaceuticals. Inc. · Uncontrolled Hypertension

  • RTP-026Phase 21 trial

    ResoTher Pharma · ST Elevation Myocardial Infarction

  • SAB-142Phase 21 trial

    SAb Biotherapeutics, Inc. · Type 1 Diabetes

  • SAL0150Phase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, T2DM

  • scp776allPhase 21 trial

    Silver Creek Pharmaceuticals · Acute Ischemic Stroke (AIS)

  • SNP318Phase 21 trial

    SciNeuro · Diabetic Macular Edema, DME

  • SolbinsiranLY3561774Phase 21 trial

    Eli Lilly · Severe Hypertriglyceridemia

  • SPC 2002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC 2003Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC 2004Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC1001Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5003Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5004Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPH3127Phase 21 trial

    Shanghai Pharmaceuticals Holding Co., Ltd · Diabetic Kidney Disease

  • SRD-001Phase 21 trial

    Sardocor Corp. · Congestive Heart Failure, Heart Failure, Systolic, Heart Failure

  • SRSD384Phase 21 trial

    Sirius Therapeutics Co., Ltd. · Overweight , Obesity

  • STSA-1301Phase 21 trial

    Jiangsu BioJeTay Biotechnology Co., Ltd. · Primary Immune Thrombocytopenia (ITP)

  • SYH2062Phase 21 trial

    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mild to Moderate Primary Hypertension

  • SYH2070Phase 21 trial

    CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mixed Hyperlipidemia

  • Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation

  • TB-500Phase 21 trial

    Hudson Biotech · Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction

  • TBO-309Phase 21 trial

    ThromBio Pty. Ltd. · Ischemic Stroke, Tandem Occlusion

  • TCMCB07Phase 21 trial

    Endevica Bio · Cancer Weight Loss

  • TERN-601Phase 21 trial

    Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · Overweight or Obesity

  • TGD001Phase 21 trial

    TargED Biopharmaceuticals B.V. · Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia

  • THDBH120Phase 21 trial

    Tonghua Dongbao Pharmaceutical Co.,Ltd · Overweight or Obese

  • TrevogrumabREGN1033, GDF8Phase 21 trial

    Regeneron · Obesity

  • TrizepatidePhase 21 trial

    Novo Nordisk · Diabetes Mellitus, Type 2

  • VB19055Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Hypertension, Resistant Hypertension, Uncontrolled Hypertension

  • VERVE-102LY4636581Phase 21 trial

    Eli Lilly · Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia

  • VTX2735LY5625574Phase 21 trial

    Zomagen Biosciences Ltd. · Recurrent Pericarditis

  • VX-01Phase 21 trial

    Vantage Biosciences Ltd · Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy

  • VX-264Phase 21 trial

    Vertex Pharmaceuticals · Type 1 Diabetes

  • WAL0921Phase 21 trial

    Walden Biosciences · Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease

  • WVE-007Phase 21 trial

    Wave Life Sciences USA, Inc. · Overweight and Obesity

  • XY03-EAper dosePhase 21 trial

    Shijiazhuang Yiling Pharmaceutical Co. Ltd · Stroke, Ischemic

NewerPage 10 of 11Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.